Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH -Mutant Gliomas
2014
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Chaetocin-induced ROS-mediated apoptosis involves ATM–YAP1 axis and JNK-dependent inhibition of glucose metabolism
2014
The molecular hallmarks of epigenetic control
2016 Standout
Genetics of adult glioma
2012
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
The future of high-grade glioma: Where we are and where are we going
2015
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
2015
Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
2019
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
2013
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors
2013
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
2014 StandoutNobel
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
2013
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
2014
The yeast chromatin remodeler Rsc1-RSC complex is required for transcriptional activation of autophagy-related genes and inhibition of the TORC1 pathway in response to nitrogen starvation
2015 StandoutNobel
The 2016 World Health Organization classification of tumours of the central nervous system
2018
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
2015
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
Glioblastoma: pathology, molecular mechanisms and markers
2015
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability
2016 StandoutNobel
Epigenetic Determinants of Cancer
2016
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
2014
Hypoxia Induces Production of L-2-Hydroxyglutarate
2015
What do we know about IDH1/2 mutations so far, and how do we use it?
2013
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Fundamentals of cancer metabolism
2016 Standout
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL −/− clear cell renal carcinoma
2017 StandoutNobel
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics
2018
Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma
2019
Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing
2018
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Works of Daniel Gorovets being referenced
IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma
2012
Histone 3 Lysine 9 Trimethylation Is Differentially Associated With Isocitrate Dehydrogenase Mutations in Oligodendrogliomas and High-Grade Astrocytomas
2013
Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
2012
Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years
2015